168 related articles for article (PubMed ID: 33923724)
1. In Vitro Characterization of Neutralizing Hen Antibodies to
Mwale PF; Lee CH; Huang PN; Tseng SN; Shih SR; Huang HY; Leu SJ; Huang YJ; Chiang LC; Mao YC; Wang WC; Yang YY
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923724
[No Abstract] [Full Text] [Related]
2. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
3. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
[TBL] [Abstract][Full Text] [Related]
5. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
[TBL] [Abstract][Full Text] [Related]
6. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
[TBL] [Abstract][Full Text] [Related]
7. Identification and production of mouse scFv to specific epitope of enterovirus-71 virion protein-2 (VP2).
Thanongsaksrikul J; Srimanote P; Tongtawe P; Glab-Ampai K; Malik AA; Supasorn O; Chiawwit P; Poovorawan Y; Chaicumpa W
Arch Virol; 2018 May; 163(5):1141-1152. PubMed ID: 29356992
[TBL] [Abstract][Full Text] [Related]
8. Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection.
Luo J; Huo C; Qin H; Hu J; Lei L; Pan Z
Vaccine; 2021 Jul; 39(30):4135-4143. PubMed ID: 34116877
[TBL] [Abstract][Full Text] [Related]
9. A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potential.
Zhou B; Xu L; Zhu R; Tang J; Wu Y; Su R; Yin Z; Liu D; Jiang Y; Wen C; You M; Dai L; Lin Y; Chen Y; Yang H; An Z; Fan C; Cheng T; Luo W; Xia N
Antiviral Res; 2019 Jan; 161():28-35. PubMed ID: 30419253
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand.
Lerdsamran H; Prasertsopon J; Mungaomklang A; Klinmalai C; Noisumdaeng P; Sangsiriwut K; Tassaneetrithep B; Guntapong R; Iamsirithaworn S; Puthavathana P
Virol J; 2018 Oct; 15(1):158. PubMed ID: 30326914
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
12. Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.
Gong M; Zhu H; Zhou J; Yang C; Feng J; Huang X; Ji G; Xu H; Zhu P
J Virol; 2014 Jun; 88(11):6444-52. PubMed ID: 24672036
[TBL] [Abstract][Full Text] [Related]
13. Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine.
Li J; Liu G; Liu X; Yang J; Chang J; Zhang W; Yu XF
Viruses; 2015 Jul; 7(7):3891-909. PubMed ID: 26193302
[TBL] [Abstract][Full Text] [Related]
14. Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16.
Shi J; Huang X; Liu Q; Huang Z
Vaccine; 2013 Apr; 31(17):2130-6. PubMed ID: 23499595
[TBL] [Abstract][Full Text] [Related]
15. Non-neutralizing monoclonal antibody targeting VP2 EF loop of Coxsackievirus A16 can protect mice from lethal attack via Fc-dependent effector mechanism.
Du R; An C; Yao X; Wang Y; Wang G; Gao F; Bian L; Hu Y; Liu S; Zhao Q; Mao Q; Liang Z
Emerg Microbes Infect; 2023 Dec; 12(1):2149352. PubMed ID: 36395069
[TBL] [Abstract][Full Text] [Related]
16. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71.
Zhang C; Yang Y; Chi Y; Yin J; Yan L; Ku Z; Liu Q; Huang Z; Zhou D
Vaccine; 2015 Sep; 33(39):5087-94. PubMed ID: 26296491
[TBL] [Abstract][Full Text] [Related]
17. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection.
Cai Y; Liu Q; Huang X; Li D; Ku Z; Zhang Y; Huang Z
Vaccine; 2013 Apr; 31(18):2215-21. PubMed ID: 23499596
[TBL] [Abstract][Full Text] [Related]
18. The Bottlenecks of Preparing Virus Particles by Size Exclusion for Antibody Generation.
Lee CH; Huang PN; Mwale PF; Wang WC; Leu SJ; Tseng SN; Shih SR; Chiang LC; Mao YC; Tsai BY; Dlamini NB; Nguyen TC; Tsai CH; Yang YY
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361757
[TBL] [Abstract][Full Text] [Related]
19. Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates.
Li J; Chang J; Liu X; Yang J; Guo H; Wei W; Zhang W; Yu XF
J Gen Virol; 2014 May; 95(Pt 5):1083-1093. PubMed ID: 24496826
[TBL] [Abstract][Full Text] [Related]
20. Study of integrated protective immunity induced in rhesus macaques by the intradermal administration of a bivalent EV71-CA16 inactivated vaccine.
Fan S; Liao Y; Jiang G; Jiang L; Wang L; Xu X; Feng M; Yang E; Zhang Y; Cui W; Li Q
Vaccine; 2020 Feb; 38(8):2034-2044. PubMed ID: 31982260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
